Medical 3D Printing Breakthroughs Keep on Coming

Posted by Tom Penrice on Thu,Aug 04, 2016 @ 09:00 AM

Medical 3D printing looks very promising based on recent progress. Organ transplants using 3D "living" body parts may be coming in the next few years.Medical 3D printing is making quick leaps and bounds and could soon be such a key integrated part of the medical world that we will wonder how we ever lived without it.

Doctors are now able to print 3D “living” body parts – which will be a significant advancement for regenerative medicine. A positive breakthrough has already been made, with the successful implantation of bone, muscle and cartilage into animals.

Previously, the field had hit a wall: keeping the cells alive was difficult, as they became starved of oxygen and nutrients. This problem led to a very promising solution by the team at Wake Forest Baptist Medical Centre.


The Sponge

It is exactly what it sounds like. The Wake Forest team developed the idea of printing the tissue with channels interwoven throughout to allow key ntrients to pass through it.

How can a “living” body part be printed with these channels? Through the Integrated Tissue and Organ Printing System (ITOP), which utilizes a bio-degradable plastic to give the tissue its structure, as well as a water-based gel that contains the cells and encourages growth.

These channels allow blood vessels and nerves to grow into the printed tissue. Before the ITOP 3D printer, the largest structure to be kept alive without blood cells was 0.007 inches thick. With the ITOP size isn’t an issue, as the microscopic pores are interwoven into the printed structure allowing the i
plant to be kept alive indefinitely.

Are 3D Organ Transplants Next?

This development gives 3D organ printing a promising outlook. Within the next few years we could be expecting success stories on artificial heart, liver, kidney, and other major organ transplants, giving many on the transplant list hope. Pennside will continue to follow the development of 3D printing in the healthcare industry.

If you aren’t familiar with how 3D printing is impacting the pharma and biotech industry check out Pennside’s earlier blog postings to learn more.

The above post is a condensed and edited summary of NBC News: Wake Forest University Scientists Print Living Body Parts, BBC News: Doctors 3D-print 'living' body parts and Popular Mechanics: Incredible 3D Printer Can Make Bone, Cartilage, and Muscle


Pennside Partners is a leading pharmaceutical and biotech consulting firm with over 25 years experience. They have offices in the United States, United Kingdom, and Switzerland.

Tags: 3D Body Parts, 3D Organ Printing, Medical 3D Printing

Receive Blog Posts by Email

Follow Us

Learn More About Our Services

Learn more about Pennside's pharma war games, strategy workshops, and competitive simulations for the pharma and biotech industries


Learn more about Pennside's pharma launch analog services, including pharma business development, pharma benchmarking, pharma best practices, pharma business analytics, business intelligence, ci, competitive intelligence, pharma launch planning, and other strategic consulting services for the pharmaceutical industry. 

Learn more about Pennside's  pharmaceutical and biotechnology consulting services spanning the following areas: competitive intelligence and monitoring, pipeline analysis and disease landscape consulting, marketing/sales/reimbursement support benchmarking, launch support and best practices benchmarking, customer facing and new commercial models, licensing and support consulting, strategy workshops, and outsourced business intelligence and fixed term contractors consulting for the pharma and biotech industries. 

Learn more about Pennside's Robust Pharma Competitive Intelligence and CI Monitoring Services. We provide superior pharma strategies based on actionable corporate intelligence. 

Learn more about our Oncology Drug Development Support Services: oncology launch analog service, oncology congress coverage service, post-launch intelligence and market monitoring, oncology business development and licensing and M&A support, and tumor/MOA clinical pipeline analysis services. Oncology launch adoption and market strategy services include: launch planning support, primary field intelligence and market insights, oncology competitive pipeline analysis, inlicensing reviews, oncology biomarker analysis, and benchmarking of oncology organizations. Oncology Congress Coverage services include: preparing a targeted congress schedule, attending and capturing key oncology conference information, and presenting oncology conference findings.

Contact Us or Request Information

Experience You Can Trust

Trusted pharma and biotech consulting experts for over 25 years